EUVIMEDEUVIMED entdecken
Crossref

Peripheral blood eosinophilia does not represent a reliable biomarker for prediction of response to treatment with type-2 biologics in patients with CRSwNP

Sebastian Kotz, Zhaojun Zhu, Claudia Jerin, Evamaria Stütz, Constanze Jakwerth, Barbara Wollenberg, Carsten Schmidt-Weber, Adam Chaker

Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S322

DOI: 10.1055/s-0044-1785092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Sebastian Kotz und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type-2 biologics allow for successful treatment of patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP). Eosinophils have been established as a reliable biomarker of type-2 disease and enable the differentiation of inflammatory patterns in CRSwNP. Aim of this study was to evaluate, whether peripheral blood eosinophilia before initiation of therapy with type-2 biologics allows assesment of response to treatment in patients with CRSwNP.

Methods

We analyzed 55 patients with CRSwNP who were treated with type-2 biologics in our ENT-clinics for at least 12 months. The following parameters were assesed in all subjects before first treatment was administered: serum IgE, differential blood count, nasal polyp score (NPS) and SNOT-22. After 12 months, response to treamtent was evaluated using clinical parameters NPS and SNOT-22. Patients with hypereosinophilia underwent further evaluation.

Results

At 12 months, there was a low-to-moderate correlation of baseline eosinophils with reduction of NPS (ΔNPS%, r=0.27, p

Zitieren

APA

Kotz, S., Zhu, Z., Jerin, C., Stütz, E., Jakwerth, C., Wollenberg, B., Schmidt-Weber, C., & Chaker, A. (2024). Peripheral blood eosinophilia does not represent a reliable biomarker for prediction of response to treatment with type-2 biologics in patients with CRSwNP. Laryngo-Rhino-Otologie, 103(S 02 S 02), S322. https://doi.org/10.1055/s-0044-1785092

Vancouver

Kotz S, Zhu Z, Jerin C, Stütz E, Jakwerth C, Wollenberg B, et al. Peripheral blood eosinophilia does not represent a reliable biomarker for prediction of response to treatment with type-2 biologics in patients with CRSwNP. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S322. doi:10.1055/s-0044-1785092

BibTeX
@article{Kotz2024,
  author = {Kotz, Sebastian and Zhu, Zhaojun and Jerin, Claudia and Stütz, Evamaria and Jakwerth, Constanze and Wollenberg, Barbara and Schmidt-Weber, Carsten and Chaker, Adam},
  title = {Peripheral blood eosinophilia does not represent a reliable biomarker for prediction of response to treatment with type-2 biologics in patients with CRSwNP},
  journal = {Laryngo-Rhino-Otologie},
  year = {2024},
  volume = {103},
  number = {S 02 S 02},
  pages = {S322},
  doi = {10.1055/s-0044-1785092}
}
Kostenlos starten →